MeiraGTx Holdings plc Increase (Decrease) in Prepaid Expense and Other Assets
MeiraGTx Holdings plc (MGTX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $112.44 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2018-11-08
- MeiraGTx Holdings plc increase (decrease) in prepaid expense and other assets for the quarter ending 2018-09-30 was $429.57K, a 61.56% increase year-over-year.
- MeiraGTx Holdings plc increase (decrease) in prepaid expense and other assets for the quarter ending 2017-09-30 was $265.89K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month |
|---|---|---|---|
| 2018-09-30 | $429.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $112.44K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$317.13K 10-Q · filed 2018-08-08 | ||
| 2017-09-30 | $265.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $259.76K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | -$6.13K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |